Page 9 - Cannabis News July 2019
P. 9

Back Cover Story: DocMJ Educational Partner

        Anticipates Expedited Approvals for Hemp Extracted CBD Products
        with Documented Enhanced Bioavailability



         Continued from Back Page            progress working with major scientific   is that it will reduce or alleviate symp-  DocMJ anticipates endorsing the launch
          According to President/Founder of   and medical institutions, particularly in   toms, particularly pain with minimal   of a hemp extract product DocCBD this
        DocMJ, Michael Bruno, D.O, FACOI,    Israel, where government regulations do   daily doses,” Bruno said. This water-sol-  summer. It is anticipated that by pioneer-
        cannabis therapy has been impeded for   not inhibit scientific cannabis research   uble capsule, taken twice daily is expect-  ing this product with improved thera-
        the past 20 years in the states, due to   and nanotechnology.             ed to maintain a longer half-life in the   peutic value and no psychotropic side
        intricate legalities and lack of scientific   Thus, through controlled research and   patient to reduce symptoms.   effects for patients, it can attack and
        data. While CBD is broadly believed to   comparative studies a new patented CBD   “These GRAS compliant outcomes will   reduce the opiate crisis and alleviate
        have therapeutic properties which ease   product will be available in July. It has   be studied by the FDA and allow us, as   abuse potential.
        symptoms of various diseases beyond   data-backed proof that it elevates and   physicians to advise and give patients   “As practicing physicians, we are pas-
        standard treatments, its components   holds a bioavailability of 90% in an oral   access to proper dosage and strengths for   sionate about this product because it is
        have a poor shelf life and unstable   administration, the route of choice.   relief,” he explained. “We are excited   the first physician-endorsed oral CBD
        bioavailability (degree of absorption   Furthermore, the precise, patented tech-  about this groundbreaking opportunity,”   product backed by scientific data to sup-
        through    the    blood    stream).  nology withstands GRAS (generally rec-  he continued, “because it will be the first   port absorption at minimal dosages with
        Bioavailability is impacted by route of   ognized as safe) scrutiny with a high   nutraceutical OTC capsule which can   no conversion to THC or psychotropic
        administration, stability, and water solu-  likelihood of FDA trials scheduled for   make these legitimate claims.”   side effects,” Dr. Bruno summarized.
        bility among many factors.           peripheral neuropathy.                                                     Doc MJ was established in 2016 as a
          The pharmacology of chemical compo-  According to Dr. Bruno, medical pro-  Paradigm Shift Improves          gateway to provide knowledgeable,
        nent effectiveness is complicated and   fessionals are always looking for the   Quality and Safety            affordable medical advice and determine
        hinders the capability for consumers to   most effective and safe means to pre-  The paradigm shift is connecting with   benefits regarding marijuana therapy to
        be able to distinguish quality and   scribe   medicine    administration.  physicians like Doc MJ who believe in   patients. “We have an extremely low
        strength of what they may purchase in   Predictably, oral and vaporized delivery   medical cannabis and have the academic   turnover of dedicated physicians and
        retail outlets or online. These circum-  of CBD are the most effective routes   and experiential knowledge to be able to   have grown to more than 23 locations
        stances provide prime opportunities for   related to outcomes and positive impact   prescribe for patients.    throughout Florida because of personal
        scams and misuse. False and misleading   on patient compliance; however, instabil-  This unique marketing route to physi-  and professional values,” Bruno said.
        claims based on obsolete or non-existent   ity and water solubility are consistent   cians, rather than direct to consumer,   “Our goal is to cut through the many
        technology can render many products as   difficulties with CBD, resulting in the   promises to result in a safer, more   fraudulent claims regarding CBD prod-
        nothing more than proverbial snake oil.   need for massive dosage recommenda-  impactful delivery of a standard of care in   ucts and provide our patients with rec-
          “The consumer may feel assured that   tions in order to achieve results. “Now   the near future.            ommendations for this breakthrough,
        there is cannabis contained in the prod-  we can recommend an affordable oral   And, DocMJ is committed to tailoring   orally administered hemp derived
        uct they purchase; however, while this   product with scientific proof that sup-  care to patients with a money back guar-  patented CBD capsule that is backed by
        may be true, it is well studied that many   ports the medicinal benefits - plus a   antee if individuals do not qualify for a   scientific data.”
        current over the counter CBD products   bioavailability of 90% that exceeds most   recommendation.
        are innately weak with under 10%     products and has a shelf life of two years.   While CBD in the USA remains in a   For information, email info@docmj.com
        bioavailability,” Dr. Bruno explained.    “We are learning from these cutting-  grey zone legally, Ananda Scientific has   or call (888) 778-2409. The DocCBD web-
          This year Mark Rosenfeld PhD, of   edge studies that by improving the stabil-  partnered with leading clinical experts   site, live as of July, is www.DOC-CBD.com
        Ananda Scientific, shared information   ity, this hemp derived CBD stays in the   worldwide conducting science-based          or call (888) 316-6659.
        with DocMJ regarding trailblazing    blood stream longer and the bottom line   R&D for expedited FDA approval.



                                                                                                              www.CannabisNewsFlorida.com
                                                                                      Visit us on the web at www.CannabisNewsFlorida.com








                  Florida’s Resource for                       JUDY GRAMM
         Medical & Business Cannabis Developments      Editorial Manager

                    PO Box 812708                  CONTRIBUTING WRITERS
                Boca Raton, FL 33481-2708               Daniel Casciato
                  Phone: (561) 368-6950                 Barbara Fallon
                                                         Vanessa Orr
                       Website:                         Lois Thomson
               www.cannabisnewsflorida.com
                                                       SUBSCRIPTIONS
                    CHARLES FELIX                       One Year - $45
                     CAROL FELIX                        Two Years - $70
                      Publishers                       Three Years - $85

                    ANDREW FELIX                To subscribe, call (561) 368-6950
                     Editor-in-Chief                      Or email:

                                                 carol@cannabisnewsflorida.com
                    NANCY LAMMIE
                     JMC Graphics                  All rights reserved. Reproduction
                     Art/Production                In whole or part without written
                                                     permission is prohibited.
                                                       Copyright ©2019



         28                       July 2019                                                                    cannabisnewsflorida.com                                                                                     Cannabis News Florida
   4   5   6   7   8   9   10   11